Hayakawa N, Kikuchi E, Mizuno R, Oya M. The role of programmed cell death-1 positivity in tumor nest on clinical outcome in upper tract urothelial carcinoma patients treated with radical nephroureterectomy. EMUC 2017, O3.
Europese goedkeuring pembrolizumab bij NSCLC met tumor-PD-L1 expressie ≥ 50%
feb 2017 | Longoncologie